Rizzo, M., Rizvi, A.A., Rini, G.B., Berneis, K. (2009). The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?. ACTA DIABETOLOGICA, 46(1), 1-11.

The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

RIZZO, Manfredi;RINI, Giovam Battista
2009-01-01

2009
Rizzo, M., Rizvi, A.A., Rini, G.B., Berneis, K. (2009). The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?. ACTA DIABETOLOGICA, 46(1), 1-11.
File in questo prodotto:
File Dimensione Formato  
59 Acta Diabetol 2009.pdf

Solo gestori archvio

Dimensione 332.82 kB
Formato Adobe PDF
332.82 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/77617
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? ND
social impact